As Cipla approaches its centenary, the company is redefining its strategy by prioritizing innovation to amplify revenues. With ambitions to...

Pfizer is prioritizing India for future growth. The company plans to launch new medicines here soon after their global release. Pfizer aims...

Dr Reddy's Laboratories anticipates a gradual recovery this fiscal year. The company faced a profit drop last year due to US business press...

India’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...

Geopolitical tensions in West Asia are manageable now. However, a prolonged US-Israel war against Iran could raise costs for petrochemical-...

The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...

Sun Pharmaceutical Industries' shares surged after announcing the $11.75 billion acquisition of US-based Organon & Co., a global leader in ...

India's weight-loss drug market is seeing a major shift. Generic versions of Novo Nordisk's semaglutide are now available at lower prices. ...

The recent decision by US President Donald Trump to impose a 100 per cent tariff on patented pharmaceutical imports to US is unlikely to ca...

"We are pleased with the first-to-market launch of two of our six strengths of Lenalidomide Capsules with 180-day market exclusivity. Bring...

"Ranbaxy is disappointed with this development & is actively evaluating all available options to preserve its rights," company said in a st...

Indian generic drug producers are devising fresh strategies to continue benefiting from the world’s largest pharmaceutical market the Unite...

Mylan has sued USFDA for not allowing it to market a generic version of medicine Diovan, saying that Ranbaxy has lost its exclusivity for t...

The company is yet to get the US food and Drug Administration's approval for the generic version of the drug, valsartan.

Generic drug makers, which have typically waged legal battles against innovator pharma giants, are now suing each other to protect their ma...

Three US senators have introduced a bill in the US senate to try and prevent global pharma giants from selling cheaper copies of their own ...

The path was cleared for generic versions of Merck’s blockbuster Zocor cholesterol drug on Friday, after a US federal judge rejected a last...